Sign In
Buy TNON
$0.630
+0.0046 (+0.736%)
At Close: Jun 03, 2026
Tenon Medical Reports First Quarter 2025 Financial Results
04:05pm, Tuesday, 13'th May 2025
~ FDA Clearance of Catamaran® SI Joint Fusion System for New Indication to Augment Spinal Fusion ~ ~ Catamaran® SI Joint Fusion Technology Protected with Robust Patent Portfolio of Twelve U.S. and I
Tenon Medical, Inc. Announces Timing of First Quarter 2025 Financial Results
04:05pm, Tuesday, 29'th Apr 2025
LOS GATOS, CA / ACCESS Newswire / April 29, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ)
LOS GATOS, CA / ACCESS Newswire / March 25, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Jo
Tenon Medical, Inc. Announces a Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
12:45pm, Tuesday, 25'th Mar 2025
LOS GATOS, CA / ACCESS Newswire / March 25, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Jo
Tenon Medical(R) Announces FDA Clearance of Catamaran(R) SI Joint Fusion System for New Indication to Augment Spinal Fusion
04:05pm, Monday, 24'th Mar 2025
~ Achieves Significant Milestone with Expanded Use Indication, Opens Sizable New SI Market Opportunity ~ LOS GATOS, CA / ACCESS Newswire / March 24, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" o
Tenon Medical, Inc. (TNON) Q4 2024 Earnings Call Transcript
06:40pm, Thursday, 20'th Mar 2025
Tenon Medical, Inc. (NASDAQ:TNON ) Q4 2024 Earnings Conference Call March 20, 2025 4:30 PM ET Company Participants Steve Foster - President and CEO Kevin Williamson - Chief Financial Officer Conferenc
Tenon Medical Reports Fourth Quarter and Full Year 2024 Financial Results
04:05pm, Thursday, 20'th Mar 2025
~ Full Year 2024 Revenue of $3.3 Million, a 12% Increase Compared to Prior Year ~ ~ Interim Analysis from MAINSAIL Study Reinforces Safety Profile, Effectiveness and Confirmation of Fusion ~ ~ Catamar
Tenon Medical, Inc. Announces a Warrant Inducement Transaction for $3.0 Million in Gross Proceeds
03:40pm, Tuesday, 11'th Mar 2025
LOS GATOS, CA / ACCESS Newswire / March 11, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Jo
Tenon Medical(R) Receives Approval for Notice of Allowance from the European Patent Office
04:05pm, Monday, 10'th Mar 2025
LOS GATOS, CA / ACCESS Newswire / March 10, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ)
Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2024 Financial Results
08:00am, Friday, 07'th Mar 2025
LOS GATOS, CA / ACCESS Newswire / March 7, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) d
Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco
08:00am, Thursday, 09'th Jan 2025
LOS GATOS, CA / ACCESSWIRE / January 9, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) diso
Tenon Medical, Inc. (TNON) Q3 2024 Earnings Call Transcript
06:21pm, Wednesday, 13'th Nov 2024
Tenon Medical, Inc. (NASDAQ:TNON ) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants Steven Foster - President & CEO Kevin Williamson - CFO Conference Call Participant
Tenon Medical Reports Third Quarter 2024 Financial Results
04:05pm, Wednesday, 13'th Nov 2024
~ 3Q Revenue of $0.9 Million, Consistent with Prior Quarter; Year to Date Revenue of $2.5 Million, Growth of 18.3% Compared to Prior Year ~ ~ Published Interim Analysis from MAINSAIL™ Study; Post-Ma
Tenon Medical, Inc. Announces Timing of Third Quarter 2024 Financial Results
08:00am, Wednesday, 30'th Oct 2024
LOS GATOS, CA / ACCESSWIRE / October 30, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) dis
Tenon Medical(R) Regains Full Compliance with Nasdaq Continued Listing Requirements
08:00am, Monday, 28'th Oct 2024
LOS GATOS, CA / ACCESSWIRE / October 28, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) dis
